Product Details
Covid-19 Neutralizing Antibodies Test Kit (Latex particle-enhanced
turbidimetric immunoassay)
Test principle
SARS-CoV-2 antibodies in the specimen react with latex particles
coated with SARS-CoV-2 antigens through agglutination, resulting
antigen-antibody-latex complexes.
The antigen-antibody-latex complexes cause an increase in
absorbance, which is proportional to the concentration of
SARS-CoV-2 antibodies in the specimen in the presence of excess antigen. The absorbance is measured by reading
turbidity. The antibody concentration in the specimen is determined
by comparing the absorbance to the standard curve.
The sensitivity of this assay early after infection is unknown.
Negative results do not preclude acute SARS-CoV-2 infection. If
acute infection is suspected, direct testing for SARS-CoV-2 is necessary. False positive results for the
This assay may occur due to cross reactivity from pre-existing
antibodies or other possible causes.
Product information
Principe | Latex Particle- Enhanced Turbidimetric Turbidimetric |
Specimen | Plasma,Serum |
Sample Volume | 10µL |
Package | 100 tests/kit |
Storage | 2-8°C |
Shelf Life | 12 months |
Company Profile
Shenzhen Kisshealh Biotechnology Co., Ltd., located in the Pingshan
District, Shenzhen, P.R. China. is a diagnostics company focused on
the development and manufacture of IVD tests at the Point-of-Care
with highly innovative proprietary technology.
We focused on the emerging markets of in vitro pathological
diagnosis and immunodiagnosis. We developed, manufactured and
successfully launched the in vitro immunodiagnosis platform for
cancer and the POCT for infectious, genetic and chronic diseases.
<span style="color: rgb(33, 33, 33); text-transform: none;
text-indent: 0px; letter-spacing: normal;" initial;"="" initial;=""
0px;="" normal;="" 255);="" 255,="" rgb(255,="" 2;=""
!important;="" inline="" none;="" 600;="" 14px;="" sans-serif;=""
arial,="" roboto,="" w3",="" gb="" sans="" "hiragino="" gb",=""
hei",="" micro="" "wenquanyi="" sans",="" "droid="" arimo,=""
freesans,="" yahei",="" "microsoft="" helvetica,="" grande",=""
"lucida="" ui",="" segoe="">At Kissh we work every day to shape
the future of in-vitro diagnostic testing. And our people are our
best asset, the reason for our track record and our strength while
we are moving forward. We live by our fundamental values and
incorporate them in everything that we do. Our best asset is ‘Step
Forward Every Second’